4.6 Review

The Role of Macrophage Migration Inhibitory Factor in Alzheimer ' s Disease: Conventionally Pathogenetic or Unconventionally Protective?

期刊

MOLECULES
卷 25, 期 2, 页码 -

出版社

MDPI
DOI: 10.3390/molecules25020291

关键词

Alzheimer ' s disease; macrophage migration inhibitory factor; neuroinflammation

向作者/读者索取更多资源

Recent preclinical and clinical observations have offered relevant insights on the etiopathogenesis of late onset Alzheimer ' s disease (AD) and upregulated immunoinflammatory events have been described as underlying mechanisms involved in the development of AD. Macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine produced by several cells of the innate and adaptive immune system, as well as non-immune cells. In the present review, we highlight experimental, genetic, and clinical studies on MIF in rodent models of AD and AD patients, and we discuss emerging therapeutic opportunities for tailored modulation of the activity of MIF, that may potentially be applied to AD patients. Dismantling the exact role of MIF and its receptors in AD may offer novel diagnostic and therapeutic opportunities in AD.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Neurosciences

mGlu3 Metabotropic Glutamate Receptors as a Target for the Treatment of Absence Epilepsy: Preclinical and Human Genetics Data

Roberta Celli, Pasquale Striano, Rita Citraro, Luisa Di Menna, Milena Cannella, Tiziana Imbriglio, Mahmoud Koko, Euro Epinomics-Cogie Euro Epinomics-Cogie Consortium, Giovambattista De Sarro, James A. Monn, Giuseppe Battaglia, Gilles van Luijtelaar, Ferdinando Nicoletti, Emilio Russo, Antonio Leo

Summary: Previous studies suggest that modulation of mGlu3 receptors may be a potential treatment for absence epilepsy. This study found that mGlu3 receptor expression and signaling were decreased in the somatosensory cortex and thalamus of epileptic rats, and selective activation of mGlu3 receptors reduced seizures and depressive-like behavior. However, no association was found between genetic variants of GRM3 and absence epilepsy.

CURRENT NEUROPHARMACOLOGY (2023)

Article Immunology

The combination of gemcitabine and ginsenoside Rh2 enhances the immune function of dendritic cells against pancreatic cancer via the CARD9-BCL10-MALT1/NF-κB pathway

Qing Li, Jialuo He, Senlin Li, Cheng Tian, Jian Yang, Huimin Yuan, Yi Lu, Paolo Fagone, Ferdinando Nicoletti, Ming Xiang

Summary: Pancreatic cancer (PC) has a cold tumor immune microenvironment (TIME) with minimal dendritic cell (DC) and T cell infiltration, leading to inadequate immunotherapy and chemotherapy. Combining gemcitabine (GEM) with ginsenoside Rh2 (Rh2) can enhance tumor immunogenicity and induce lasting anti-tumor immunity in PC. The activation of DCs by Rh2 via the CARD9-BCL10-MALT1/NF-KB pathway may reverse the cold TIME and optimize GEM chemotherapy, providing a potentially feasible and safe treatment strategy for PC.

CLINICAL IMMUNOLOGY (2023)

Review Biochemistry & Molecular Biology

Preventive and Therapeutic Effects of Punica granatum L. Polyphenols in Neurological Conditions

Simona Aleksandrova, Ralitza Alexova, Stela Dragomanova, Reni Kalfin, Ferdinando Nicoletti, Paolo Fagone, Maria Cristina Petralia, Katia Mangano, Lyubka Tancheva

Summary: Pomegranate is a polyphenol-rich food and medicinal plant that contains various beneficial compounds. Studies have shown that these compounds can target brain cells and support their functions by regulating redox balance, proliferation, and survival. The neuroprotective effects of pomegranate are mediated by its antioxidant and anti-inflammatory properties, ability to activate signaling pathways, and regulation of mitochondrial damage. In vitro and in vivo studies have demonstrated that pomegranate polyphenols can directly affect neuronal and glial cells, as well as influence blood-brain barrier function and increase blood flow to the brain.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

Rationale for Use of Sphingosine-1-Phosphate Receptor Modulators in COVID-19 Patients: Overview of Scientific Evidence

Thomas Hach, Kasra Shakeri-Nejad, Marc Bigaud, Frank Dahlke, Massimiliano de Micco, Olivier Petricoul, Gordon Graham, Daniela Piani-Meier, Renato Turrini, Volker Brinkmann, Ferdinando Nicoletti

Summary: Maladjusted immune responses to COVID-19 can lead to immunopathology and acute respiratory distress syndrome. Sphingosine-1-phosphate and its receptors play a crucial role in maintaining endothelial cell chemotaxis and barrier integrity. S1PR modulators can attenuate cytokine release and enhance the pulmonary endothelial barrier. Certain drugs used in multiple sclerosis have shown effectiveness and potential in COVID-19 patients.

JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2023)

Article Neurosciences

Common and Rare Variants in TMEM175 Gene Concur to the Pathogenesis of Parkinson's Disease in Italian Patients

Nicole Piera Palomba, Giorgio Fortunato, Giuseppe Pepe, Nicola Modugno, Sara Pietracupa, Immacolata Damiano, Giada Mascio, Federica Carrillo, Luca Giovanni Di Giovannantonio, Laura Ianiro, Katiuscia Martinello, Viola Volpato, Vincenzo Desiato, Riccardo Acri, Marianna Storto, Ferdinando Nicoletti, Caleb Webber, Antonio Simeone, Sergio Fucile, Vittorio Maglione, Teresa Esposito

Summary: This study focuses on the common and rare variants identified in the lysosomal K+ channel TMEM175 and their association with Parkinson's disease. Through clinical and genetic analysis, the study identified several common variants and 13 highly penetrant detrimental mutations in the TMEM175 gene. Functional analysis revealed a loss of K+ conductance and impaired autophagic/lysosomal proteolytic flux in patient-derived cells, suggesting a potential role of TMEM175 gene mutations in the pathophysiology of PD.

MOLECULAR NEUROBIOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Role of Dickkopf-3 in Blood Pressure Regulation in Mice and Hypertensive Rats

Carla Letizia Busceti, Albino Carrizzo, Franca Bianchi, Massimiliano De Lucia, Antonio Damato, Chiara Cazzin, Eleonora Venturini, Paola Di Pietro, Roxana Paula Ginerete, Luisa Di Menna, Maria Cotugno, Rosita Stanzione, Simona Marchitti, Serena Migliarino, Michele Ciccarelli, Sebastiano Sciarretta, Valeria Bruno, Giuseppe Battaglia, Francesco Fornai, Massimo Volpe, Speranza Rubattu, Ferdinando Nicoletti, Carmine Vecchione

Summary: Dkk3 plays a crucial role in cardiovascular homeostasis, and its deficiency leads to hypertension and impaired vascular function, which can be rescued by restoring Dkk3 expression. This effect is achieved through promoting VEGF expression and activating the VEGF/Akt/eNOS hypotensive pathway.

CIRCULATION RESEARCH (2023)

Review Biochemistry & Molecular Biology

Anti-COVID-19 Potential of Ellagic Acid and Polyphenols of Punica granatum L.

Ralitza Alexova, Simona Alexandrova, Stela Dragomanova, Reni Kalfin, Ayten Solak, Sidharth Mehan, Maria Cristina Petralia, Paolo Fagone, Katia Mangano, Ferdinando Nicoletti, Lyubka Tancheva

Summary: Pomegranate is a rich source of polyphenols that have anti-inflammatory and antioxidant activity, and can support the immune system during viral infection and recovery. Studies have shown that pomegranate polyphenol extract and its components can control immune cell infiltration, regulate cytokine secretion, inhibit viruses like SARS-CoV-2, and modulate the NF-κB pathway. Further research is needed to understand the interactions between polyphenols, viruses, and the host immune response.

MOLECULES (2023)

Review Medicine, General & Internal

Past, Present and (Foreseeable) Future of Biological Anti-TNF Alpha Therapy

Gian Marco Leone, Katia Mangano, Maria Cristina Petralia, Ferdinando Nicoletti, Paolo Fagone

Summary: Due to the important role of TNF-alpha in immunoinflammatory diseases, TNF-alpha inhibitors have been successfully developed and used in the treatment of autoimmune disorders. Currently, there are five approved anti-TNF-alpha drugs and biosimilars available. This review discusses the historical development, current and potential future applications, as well as the search for biomarkers to predict responsiveness to these therapies.

JOURNAL OF CLINICAL MEDICINE (2023)

Review Medicine, General & Internal

Severe COVID-19: Drugs and Clinical Trials

Hazael Ramiro Ceja-Galvez, Francisco Israel Renteria-Flores, Ferdinando Nicoletti, Jorge Hernandez-Bello, Gabriela Macedo-Ojeda, Jose Francisco Munoz-Valle

Summary: By January of 2023, the COVID-19 pandemic had resulted in 6,700,883 deaths and 662,631,114 cases worldwide, with no effective therapies or standardized treatment schemes available. This review aims to analyze the most efficient and promising therapies and drugs for prevention and treatment of severe COVID-19, providing support for healthcare professionals in choosing the best pharmacological approach.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Neurosciences

Blunted type-5 metabotropic glutamate receptor-mediated polyphosphoinositide hydrolysis in two mouse models of monogenic autism

Luisa Di Menna, Rosamaria Orlando, Giovanna 'Errico, Roxana Paula Ginerete, Agata Machaczka, Carmela Maria Bonaccorso, Andrea Arena, Michela Spatuzza, Roberta Celli, Marika Alborghetti, Eleonora Ciocca, Anna Rita Zuena, Mariarosaria Scioli, Valeria Bruno, Giuseppe Battaglia, Ferdinando Nicoletti, Maria Vincenza Catania

Summary: The involvement of mGlu5 receptors in monogenic autism has been supported by various studies, but there is a lack of research on the canonical signal transduction pathway activated by these receptors in mouse models of autism. In this study, we developed a method to assess PI hydrolysis in vivo and found that mGlu5 receptor-mediated PI hydrolysis was impaired in different brain regions of mice modeling Angelman syndrome and fragile-X syndrome. These findings provide the first evidence that the canonical transduction pathway of mGlu5 receptors is downregulated in mouse models of monogenic autism.

NEUROPHARMACOLOGY (2023)

Article Medicine, General & Internal

Exploring the Role of CD74 and D-Dopachrome Tautomerase in COVID-19: Insights from Transcriptomic and Serum Analyses

Nikola Ralchev Ralchev, Silviya Lyubenova Bradyanova, Yana Valerieva Doneva, Nikolina Mihaylova, Elena Vikentieva Elefterova-Florova, Andrey Ivanov Tchorbanov, Jose Francisco Munoz-Valle, Maria Cristina Petralia, Paola Checconi, Ferdinando Nicoletti, Paolo Fagone

Summary: The COVID-19 pandemic poses a significant threat to global public health. The involvement of CD74 and D-DT in COVID-19 patients has been investigated, and further research is needed to fully understand the mechanisms and potential therapeutic value of targeting CD74 and IL-13 in COVID-19.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Biochemistry & Molecular Biology

Evaluation of the Involvement of Heme Oxygenase-1 Expression in Discoid Lupus Erythematosus Lesions

Paolo Fagone, Eliana Piombino, Katia Mangano, Rocco De Pasquale, Ferdinando Nicoletti, Rosario Caltabiano

Summary: This study found a negative correlation between HMOX1 levels and the inflammatory status, as well as the infiltration of M1 macrophages and activated mastocytes in DLE lesions. These findings suggest that HMOX1 plays a crucial role in the regulation of inflammation in DLE and could be a potential therapeutic target and biomarker for DLE.

ANTIOXIDANTS (2023)

Meeting Abstract Gastroenterology & Hepatology

ON104, a novel bioengineered antibody targeting oxidized Macrophage Migration Inhibitory Factor (oxMIF) shows efficacy in two distinct models of experimental colitis

M. Ferhat, K. Mangano, F. Nicoletti, C. Landlinger, T. Michael

JOURNAL OF CROHNS & COLITIS (2023)

暂无数据